'en:(aa).col3a1.0'
(id=6928002 ; fe=en:(aa).col3a1.0 ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=3094 creation date=2017-06-25 touchdate=2025-07-16 16:07:52.000) ≈ 86 relations sortantes
- en:(aa).col3a1.0 --
r_associated #0: 34 / 1 ->
collagène type iii
n1=en:(aa).col3a1.0 | n2=collagène type iii | rel=r_associated | relid=0 | w=34
- en:(aa).col3a1.0 --
r_associated #0: 30 / 0.882 ->
en:alpha-n-acetylglucosaminidase
n1=en:(aa).col3a1.0 | n2=en:alpha-n-acetylglucosaminidase | rel=r_associated | relid=0 | w=30
- en:(aa).col3a1.0 --
r_associated #0: 30 / 0.882 ->
en:cob(i)alamin adenosyltransferase
n1=en:(aa).col3a1.0 | n2=en:cob(i)alamin adenosyltransferase | rel=r_associated | relid=0 | w=30
- en:(aa).col3a1.0 --
r_associated #0: 30 / 0.882 ->
en:cyclic amp-dependent transcription factor atf-1
n1=en:(aa).col3a1.0 | n2=en:cyclic amp-dependent transcription factor atf-1 | rel=r_associated | relid=0 | w=30
- en:(aa).col3a1.0 --
r_associated #0: 30 / 0.882 ->
en:t-cell surface antigen cd2
n1=en:(aa).col3a1.0 | n2=en:t-cell surface antigen cd2 | rel=r_associated | relid=0 | w=30
- en:(aa).col3a1.0 --
r_associated #0: 29 / 0.853 ->
en:25-hydroxyvitamin d-1 alpha-hydroxylase, mitochondrial
n1=en:(aa).col3a1.0 | n2=en:25-hydroxyvitamin d-1 alpha-hydroxylase, mitochondrial | rel=r_associated | relid=0 | w=29
- en:(aa).col3a1.0 --
r_associated #0: 29 / 0.853 ->
en:integrin alpha-x
n1=en:(aa).col3a1.0 | n2=en:integrin alpha-x | rel=r_associated | relid=0 | w=29
- en:(aa).col3a1.0 --
r_associated #0: 28 / 0.824 ->
collagène de type iii
n1=en:(aa).col3a1.0 | n2=collagène de type iii | rel=r_associated | relid=0 | w=28
- en:(aa).col3a1.0 --
r_associated #0: 28 / 0.824 ->
en:b-cell lymphoma 6 protein
n1=en:(aa).col3a1.0 | n2=en:b-cell lymphoma 6 protein | rel=r_associated | relid=0 | w=28
- en:(aa).col3a1.0 --
r_associated #0: 28 / 0.824 ->
en:integrin alpha-l
n1=en:(aa).col3a1.0 | n2=en:integrin alpha-l | rel=r_associated | relid=0 | w=28
- en:(aa).col3a1.0 --
r_associated #0: 28 / 0.824 ->
en:integrin beta-1
n1=en:(aa).col3a1.0 | n2=en:integrin beta-1 | rel=r_associated | relid=0 | w=28
- en:(aa).col3a1.0 --
r_associated #0: 28 / 0.824 ->
en:translation initiation factor eif-2b subunit epsilon
n1=en:(aa).col3a1.0 | n2=en:translation initiation factor eif-2b subunit epsilon | rel=r_associated | relid=0 | w=28
- en:(aa).col3a1.0 --
r_associated #0: 27 / 0.794 ->
collagène type III
n1=en:(aa).col3a1.0 | n2=collagène type III | rel=r_associated | relid=0 | w=27
- en:(aa).col3a1.0 --
r_associated #0: 27 / 0.794 ->
en:fanconi anemia group c protein
n1=en:(aa).col3a1.0 | n2=en:fanconi anemia group c protein | rel=r_associated | relid=0 | w=27
- en:(aa).col3a1.0 --
r_associated #0: 27 / 0.794 ->
en:low affinity immunoglobulin gamma fc region receptor iii-b
n1=en:(aa).col3a1.0 | n2=en:low affinity immunoglobulin gamma fc region receptor iii-b | rel=r_associated | relid=0 | w=27
- en:(aa).col3a1.0 --
r_associated #0: 26 / 0.765 ->
en:integrin beta-2
n1=en:(aa).col3a1.0 | n2=en:integrin beta-2 | rel=r_associated | relid=0 | w=26
- en:(aa).col3a1.0 --
r_associated #0: 26 / 0.765 ->
en:low affinity immunoglobulin epsilon fc receptor
n1=en:(aa).col3a1.0 | n2=en:low affinity immunoglobulin epsilon fc receptor | rel=r_associated | relid=0 | w=26
- en:(aa).col3a1.0 --
r_associated #0: 26 / 0.765 ->
en:nadph-cytochrome p450 reductase
n1=en:(aa).col3a1.0 | n2=en:nadph-cytochrome p450 reductase | rel=r_associated | relid=0 | w=26
- en:(aa).col3a1.0 --
r_associated #0: 26 / 0.765 ->
en:t-cell-specific surface glycoprotein cd28
n1=en:(aa).col3a1.0 | n2=en:t-cell-specific surface glycoprotein cd28 | rel=r_associated | relid=0 | w=26
- en:(aa).col3a1.0 --
r_associated #0: 25 / 0.735 ->
en:dihydropyrimidine dehydrogenase [nadp(+)]
n1=en:(aa).col3a1.0 | n2=en:dihydropyrimidine dehydrogenase [nadp(+)] | rel=r_associated | relid=0 | w=25
- en:(aa).col3a1.0 --
r_associated #0: 25 / 0.735 ->
en:syndecan-1
n1=en:(aa).col3a1.0 | n2=en:syndecan-1 | rel=r_associated | relid=0 | w=25
- en:(aa).col3a1.0 --
r_associated #0: 24 / 0.706 ->
en:beta-ureidopropionase
n1=en:(aa).col3a1.0 | n2=en:beta-ureidopropionase | rel=r_associated | relid=0 | w=24
- en:(aa).col3a1.0 --
r_associated #0: 24 / 0.706 ->
en:carbamoyl-phosphate synthase (ammonia)
n1=en:(aa).col3a1.0 | n2=en:carbamoyl-phosphate synthase (ammonia) | rel=r_associated | relid=0 | w=24
- en:(aa).col3a1.0 --
r_associated #0: 24 / 0.706 ->
en:dna mismatch repair protein msh2
n1=en:(aa).col3a1.0 | n2=en:dna mismatch repair protein msh2 | rel=r_associated | relid=0 | w=24
- en:(aa).col3a1.0 --
r_associated #0: 23 / 0.676 ->
en:gamma-sarcoglycan
n1=en:(aa).col3a1.0 | n2=en:gamma-sarcoglycan | rel=r_associated | relid=0 | w=23
- en:(aa).col3a1.0 --
r_associated #0: 23 / 0.676 ->
en:high affinity immunoglobulin gamma fc receptor i
n1=en:(aa).col3a1.0 | n2=en:high affinity immunoglobulin gamma fc receptor i | rel=r_associated | relid=0 | w=23
- en:(aa).col3a1.0 --
r_associated #0: 22 / 0.647 ->
en:early activation antigen cd69
n1=en:(aa).col3a1.0 | n2=en:early activation antigen cd69 | rel=r_associated | relid=0 | w=22
- en:(aa).col3a1.0 --
r_associated #0: 22 / 0.647 ->
en:integrin alpha-e
n1=en:(aa).col3a1.0 | n2=en:integrin alpha-e | rel=r_associated | relid=0 | w=22
- en:(aa).col3a1.0 --
r_associated #0: 22 / 0.647 ->
en:transcription factor brn-3c
n1=en:(aa).col3a1.0 | n2=en:transcription factor brn-3c | rel=r_associated | relid=0 | w=22
- en:(aa).col3a1.0 --
r_associated #0: 21 / 0.618 ->
en:antigen ki-67
n1=en:(aa).col3a1.0 | n2=en:antigen ki-67 | rel=r_associated | relid=0 | w=21
- en:(aa).col3a1.0 --
r_associated #0: 21 / 0.618 ->
en:runt-related transcription factor 1
n1=en:(aa).col3a1.0 | n2=en:runt-related transcription factor 1 | rel=r_associated | relid=0 | w=21
- en:(aa).col3a1.0 --
r_associated #0: 21 / 0.618 ->
en:t-lymphocyte activation antigen cd80
n1=en:(aa).col3a1.0 | n2=en:t-lymphocyte activation antigen cd80 | rel=r_associated | relid=0 | w=21
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
cystathionine bêta-synthase
n1=en:(aa).col3a1.0 | n2=cystathionine bêta-synthase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:(aa).mybpc3.0
n1=en:(aa).col3a1.0 | n2=en:(aa).mybpc3.0 | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:3 beta-hydroxysteroid dehydrogenase type ii
n1=en:(aa).col3a1.0 | n2=en:3 beta-hydroxysteroid dehydrogenase type ii | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:6-pyruvoyltetrahydropterin synthase
n1=en:(aa).col3a1.0 | n2=en:6-pyruvoyltetrahydropterin synthase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:afadin, human
n1=en:(aa).col3a1.0 | n2=en:afadin, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:apolipoprotein b-48
n1=en:(aa).col3a1.0 | n2=en:apolipoprotein b-48 | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:b-cell antigen receptor complex-associated protein alpha chain
n1=en:(aa).col3a1.0 | n2=en:b-cell antigen receptor complex-associated protein alpha chain | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:biotin carboxylase
n1=en:(aa).col3a1.0 | n2=en:biotin carboxylase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:breast cancer type 1 susceptibility protein
n1=en:(aa).col3a1.0 | n2=en:breast cancer type 1 susceptibility protein | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:breast cancer type 2 susceptibility protein
n1=en:(aa).col3a1.0 | n2=en:breast cancer type 2 susceptibility protein | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:breast cancer type 2 susceptibility protein, human
n1=en:(aa).col3a1.0 | n2=en:breast cancer type 2 susceptibility protein, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:cadherin-1
n1=en:(aa).col3a1.0 | n2=en:cadherin-1 | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:cd40 ligand
n1=en:(aa).col3a1.0 | n2=en:cd40 ligand | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:cd79b gene
n1=en:(aa).col3a1.0 | n2=en:cd79b gene | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:collagen iv (alpha 3)
n1=en:(aa).col3a1.0 | n2=en:collagen iv (alpha 3) | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:complement factor h, human
n1=en:(aa).col3a1.0 | n2=en:complement factor h, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:cystathionine beta-synthase
n1=en:(aa).col3a1.0 | n2=en:cystathionine beta-synthase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:deoxyguanosine kinase
n1=en:(aa).col3a1.0 | n2=en:deoxyguanosine kinase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:dna nucleotidylexotransferase
n1=en:(aa).col3a1.0 | n2=en:dna nucleotidylexotransferase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:dopamine-beta-monooxygenase
n1=en:(aa).col3a1.0 | n2=en:dopamine-beta-monooxygenase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:fcgr2b protein, human
n1=en:(aa).col3a1.0 | n2=en:fcgr2b protein, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:folliculin
n1=en:(aa).col3a1.0 | n2=en:folliculin | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:glycogen branching enzyme
n1=en:(aa).col3a1.0 | n2=en:glycogen branching enzyme | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:hemoglobin subunit zeta
n1=en:(aa).col3a1.0 | n2=en:hemoglobin subunit zeta | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:hereditary hemochromatosis protein
n1=en:(aa).col3a1.0 | n2=en:hereditary hemochromatosis protein | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:integrin beta-3
n1=en:(aa).col3a1.0 | n2=en:integrin beta-3 | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:keratin, type ii cytoskeletal 5
n1=en:(aa).col3a1.0 | n2=en:keratin, type ii cytoskeletal 5 | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:killer cell lectin-like receptor subfamily b member 1, human
n1=en:(aa).col3a1.0 | n2=en:killer cell lectin-like receptor subfamily b member 1, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:leukosialin, human
n1=en:(aa).col3a1.0 | n2=en:leukosialin, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:mast/stem cell growth factor receptor kit
n1=en:(aa).col3a1.0 | n2=en:mast/stem cell growth factor receptor kit | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:melanoma antigen recognized by t-cells 1, human
n1=en:(aa).col3a1.0 | n2=en:melanoma antigen recognized by t-cells 1, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:methylmalonyl-coa mutase
n1=en:(aa).col3a1.0 | n2=en:methylmalonyl-coa mutase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:platelet glycoprotein ix
n1=en:(aa).col3a1.0 | n2=en:platelet glycoprotein ix | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:prions
n1=en:(aa).col3a1.0 | n2=en:prions | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:scavenger receptor cysteine-rich type 1 protein m130
n1=en:(aa).col3a1.0 | n2=en:scavenger receptor cysteine-rich type 1 protein m130 | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:scavenger receptor cysteine-rich type 1 protein m130, human
n1=en:(aa).col3a1.0 | n2=en:scavenger receptor cysteine-rich type 1 protein m130, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:serine palmitoyltransferase 1, human
n1=en:(aa).col3a1.0 | n2=en:serine palmitoyltransferase 1, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:steroid 21-monooxygenase
n1=en:(aa).col3a1.0 | n2=en:steroid 21-monooxygenase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:steryl-sulfatase
n1=en:(aa).col3a1.0 | n2=en:steryl-sulfatase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:thymidylate synthase
n1=en:(aa).col3a1.0 | n2=en:thymidylate synthase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:thyrotropin receptor
n1=en:(aa).col3a1.0 | n2=en:thyrotropin receptor | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:titin
n1=en:(aa).col3a1.0 | n2=en:titin | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:trabecular meshwork-induced glucocorticoid response protein
n1=en:(aa).col3a1.0 | n2=en:trabecular meshwork-induced glucocorticoid response protein | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:transcription factor maf
n1=en:(aa).col3a1.0 | n2=en:transcription factor maf | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:transferrin receptor
n1=en:(aa).col3a1.0 | n2=en:transferrin receptor | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:tuberin
n1=en:(aa).col3a1.0 | n2=en:tuberin | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:tyrosine-protein kinase zap-70, human
n1=en:(aa).col3a1.0 | n2=en:tyrosine-protein kinase zap-70, human | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
en:wilms tumor protein
n1=en:(aa).col3a1.0 | n2=en:wilms tumor protein | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
folliculine
n1=en:(aa).col3a1.0 | n2=folliculine | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
méthylmalonyl-CoA mutase
n1=en:(aa).col3a1.0 | n2=méthylmalonyl-CoA mutase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
méthylmalonyl-coa mutase
n1=en:(aa).col3a1.0 | n2=méthylmalonyl-coa mutase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
récepteur de la transferrine
n1=en:(aa).col3a1.0 | n2=récepteur de la transferrine | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
thymidylate synthase
n1=en:(aa).col3a1.0 | n2=thymidylate synthase | rel=r_associated | relid=0 | w=20
- en:(aa).col3a1.0 --
r_associated #0: 20 / 0.588 ->
transferrine (récepteur de la)
n1=en:(aa).col3a1.0 | n2=transferrine (récepteur de la) | rel=r_associated | relid=0 | w=20
| ≈ 98 relations entrantes
- méthylmalonyl-CoA mutase ---
r_associated #0: 69 -->
en:(aa).col3a1.0
n1=méthylmalonyl-CoA mutase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=69
- en:methylmalonyl-coa mutase ---
r_associated #0: 68 -->
en:(aa).col3a1.0
n1=en:methylmalonyl-coa mutase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=68
- en:transferrin receptor ---
r_associated #0: 59 -->
en:(aa).col3a1.0
n1=en:transferrin receptor | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=59
- récepteur de la transferrine ---
r_associated #0: 57 -->
en:(aa).col3a1.0
n1=récepteur de la transferrine | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=57
- folliculine ---
r_associated #0: 46 -->
en:(aa).col3a1.0
n1=folliculine | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=46
- méthylmalonyl-coa mutase ---
r_associated #0: 45 -->
en:(aa).col3a1.0
n1=méthylmalonyl-coa mutase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=45
- transferrine (récepteur de la) ---
r_associated #0: 44 -->
en:(aa).col3a1.0
n1=transferrine (récepteur de la) | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=44
- en:dna mismatch repair protein msh2 ---
r_associated #0: 42 -->
en:(aa).col3a1.0
n1=en:dna mismatch repair protein msh2 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=42
- en:folliculin ---
r_associated #0: 42 -->
en:(aa).col3a1.0
n1=en:folliculin | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=42
- en:low affinity immunoglobulin epsilon fc receptor ---
r_associated #0: 42 -->
en:(aa).col3a1.0
n1=en:low affinity immunoglobulin epsilon fc receptor | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=42
- en:t-lymphocyte activation antigen cd80 ---
r_associated #0: 40 -->
en:(aa).col3a1.0
n1=en:t-lymphocyte activation antigen cd80 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=40
- en:killer cell lectin-like receptor subfamily b member 1, human ---
r_associated #0: 39 -->
en:(aa).col3a1.0
n1=en:killer cell lectin-like receptor subfamily b member 1, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=39
- en:breast cancer type 1 susceptibility protein ---
r_associated #0: 38 -->
en:(aa).col3a1.0
n1=en:breast cancer type 1 susceptibility protein | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=38
- en:transcription factor brn-3c ---
r_associated #0: 38 -->
en:(aa).col3a1.0
n1=en:transcription factor brn-3c | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=38
- en:breast cancer type 2 susceptibility protein, human ---
r_associated #0: 36 -->
en:(aa).col3a1.0
n1=en:breast cancer type 2 susceptibility protein, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=36
- collagène de type iii ---
r_associated #0: 35 -->
en:(aa).col3a1.0
n1=collagène de type iii | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=35
- en:cadherin-1 ---
r_associated #0: 35 -->
en:(aa).col3a1.0
n1=en:cadherin-1 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=35
- en:cd40 ligand ---
r_associated #0: 35 -->
en:(aa).col3a1.0
n1=en:cd40 ligand | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=35
- en:deoxyguanosine kinase ---
r_associated #0: 35 -->
en:(aa).col3a1.0
n1=en:deoxyguanosine kinase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=35
- en:dihydropyrimidine dehydrogenase [nadp(+)] ---
r_associated #0: 35 -->
en:(aa).col3a1.0
n1=en:dihydropyrimidine dehydrogenase [nadp(+)] | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=35
- en:dopamine-beta-monooxygenase ---
r_associated #0: 35 -->
en:(aa).col3a1.0
n1=en:dopamine-beta-monooxygenase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=35
- en:melanoma antigen recognized by t-cells 1, human ---
r_associated #0: 35 -->
en:(aa).col3a1.0
n1=en:melanoma antigen recognized by t-cells 1, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=35
- en:titin ---
r_associated #0: 35 -->
en:(aa).col3a1.0
n1=en:titin | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=35
- en:3 beta-hydroxysteroid dehydrogenase type ii ---
r_associated #0: 34 -->
en:(aa).col3a1.0
n1=en:3 beta-hydroxysteroid dehydrogenase type ii | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=34
- en:gamma-sarcoglycan ---
r_associated #0: 34 -->
en:(aa).col3a1.0
n1=en:gamma-sarcoglycan | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=34
- en:scavenger receptor cysteine-rich type 1 protein m130 ---
r_associated #0: 34 -->
en:(aa).col3a1.0
n1=en:scavenger receptor cysteine-rich type 1 protein m130 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=34
- en:syndecan-1 ---
r_associated #0: 34 -->
en:(aa).col3a1.0
n1=en:syndecan-1 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=34
- en:thymidylate synthase ---
r_associated #0: 34 -->
en:(aa).col3a1.0
n1=en:thymidylate synthase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=34
- thymidylate synthase ---
r_associated #0: 34 -->
en:(aa).col3a1.0
n1=thymidylate synthase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=34
- collagène type III ---
r_associated #0: 32 -->
en:(aa).col3a1.0
n1=collagène type III | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=32
- collagène type iii ---
r_associated #0: 32 -->
en:(aa).col3a1.0
n1=collagène type iii | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=32
- en:alpha-n-acetylglucosaminidase ---
r_associated #0: 32 -->
en:(aa).col3a1.0
n1=en:alpha-n-acetylglucosaminidase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=32
- en:b-cell lymphoma 6 protein ---
r_associated #0: 32 -->
en:(aa).col3a1.0
n1=en:b-cell lymphoma 6 protein | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=32
- en:beta-ureidopropionase ---
r_associated #0: 32 -->
en:(aa).col3a1.0
n1=en:beta-ureidopropionase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=32
- en:cyclic amp-dependent transcription factor atf-1 ---
r_associated #0: 32 -->
en:(aa).col3a1.0
n1=en:cyclic amp-dependent transcription factor atf-1 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=32
- en:integrin beta-3 ---
r_associated #0: 32 -->
en:(aa).col3a1.0
n1=en:integrin beta-3 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=32
- en:runt-related transcription factor 1 ---
r_associated #0: 32 -->
en:(aa).col3a1.0
n1=en:runt-related transcription factor 1 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=32
- en:steroid 21-monooxygenase ---
r_associated #0: 32 -->
en:(aa).col3a1.0
n1=en:steroid 21-monooxygenase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=32
- en:antigen ki-67 ---
r_associated #0: 31 -->
en:(aa).col3a1.0
n1=en:antigen ki-67 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=31
- en:breast cancer type 2 susceptibility protein ---
r_associated #0: 31 -->
en:(aa).col3a1.0
n1=en:breast cancer type 2 susceptibility protein | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=31
- en:mast/stem cell growth factor receptor kit ---
r_associated #0: 31 -->
en:(aa).col3a1.0
n1=en:mast/stem cell growth factor receptor kit | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=31
- en:platelet glycoprotein ix ---
r_associated #0: 31 -->
en:(aa).col3a1.0
n1=en:platelet glycoprotein ix | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=31
- en:serine palmitoyltransferase 1, human ---
r_associated #0: 31 -->
en:(aa).col3a1.0
n1=en:serine palmitoyltransferase 1, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=31
- en:thyrotropin receptor ---
r_associated #0: 31 -->
en:(aa).col3a1.0
n1=en:thyrotropin receptor | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=31
- cystathionine bêta-synthase ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=cystathionine bêta-synthase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:(aa).mybpc3.0 ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:(aa).mybpc3.0 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:collagen iv (alpha 3) ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:collagen iv (alpha 3) | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:early activation antigen cd69 ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:early activation antigen cd69 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:glycogen branching enzyme ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:glycogen branching enzyme | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:high affinity immunoglobulin gamma fc receptor i ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:high affinity immunoglobulin gamma fc receptor i | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:integrin beta-1 ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:integrin beta-1 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:integrin beta-2 ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:integrin beta-2 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:prions ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:prions | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:t-cell surface antigen cd2 ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:t-cell surface antigen cd2 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:transcription factor maf ---
r_associated #0: 30 -->
en:(aa).col3a1.0
n1=en:transcription factor maf | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=30
- en:25-hydroxyvitamin d-1 alpha-hydroxylase, mitochondrial ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:25-hydroxyvitamin d-1 alpha-hydroxylase, mitochondrial | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:b-cell antigen receptor complex-associated protein alpha chain ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:b-cell antigen receptor complex-associated protein alpha chain | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:integrin alpha-e ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:integrin alpha-e | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:integrin alpha-x ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:integrin alpha-x | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:low affinity immunoglobulin gamma fc region receptor iii-b ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:low affinity immunoglobulin gamma fc region receptor iii-b | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:scavenger receptor cysteine-rich type 1 protein m130, human ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:scavenger receptor cysteine-rich type 1 protein m130, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:steryl-sulfatase ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:steryl-sulfatase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:translation initiation factor eif-2b subunit epsilon ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:translation initiation factor eif-2b subunit epsilon | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:tyrosine-protein kinase zap-70, human ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:tyrosine-protein kinase zap-70, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:wilms tumor protein ---
r_associated #0: 29 -->
en:(aa).col3a1.0
n1=en:wilms tumor protein | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=29
- en:fcgr2b protein, human ---
r_associated #0: 28 -->
en:(aa).col3a1.0
n1=en:fcgr2b protein, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=28
- en:hereditary hemochromatosis protein ---
r_associated #0: 28 -->
en:(aa).col3a1.0
n1=en:hereditary hemochromatosis protein | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=28
- en:keratin, type ii cytoskeletal 5 ---
r_associated #0: 28 -->
en:(aa).col3a1.0
n1=en:keratin, type ii cytoskeletal 5 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=28
- en:nadph-cytochrome p450 reductase ---
r_associated #0: 28 -->
en:(aa).col3a1.0
n1=en:nadph-cytochrome p450 reductase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=28
- en:t-cell-specific surface glycoprotein cd28 ---
r_associated #0: 28 -->
en:(aa).col3a1.0
n1=en:t-cell-specific surface glycoprotein cd28 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=28
- en:trabecular meshwork-induced glucocorticoid response protein ---
r_associated #0: 28 -->
en:(aa).col3a1.0
n1=en:trabecular meshwork-induced glucocorticoid response protein | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=28
- en:tuberin ---
r_associated #0: 28 -->
en:(aa).col3a1.0
n1=en:tuberin | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=28
- en:afadin, human ---
r_associated #0: 27 -->
en:(aa).col3a1.0
n1=en:afadin, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=27
- en:apolipoprotein b-48 ---
r_associated #0: 27 -->
en:(aa).col3a1.0
n1=en:apolipoprotein b-48 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=27
- en:biotin carboxylase ---
r_associated #0: 27 -->
en:(aa).col3a1.0
n1=en:biotin carboxylase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=27
- en:carbamoyl-phosphate synthase (ammonia) ---
r_associated #0: 27 -->
en:(aa).col3a1.0
n1=en:carbamoyl-phosphate synthase (ammonia) | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=27
- en:cob(i)alamin adenosyltransferase ---
r_associated #0: 27 -->
en:(aa).col3a1.0
n1=en:cob(i)alamin adenosyltransferase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=27
- en:leukosialin, human ---
r_associated #0: 27 -->
en:(aa).col3a1.0
n1=en:leukosialin, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=27
- en:6-pyruvoyltetrahydropterin synthase ---
r_associated #0: 26 -->
en:(aa).col3a1.0
n1=en:6-pyruvoyltetrahydropterin synthase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=26
- en:cd79b gene ---
r_associated #0: 26 -->
en:(aa).col3a1.0
n1=en:cd79b gene | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=26
- en:complement factor h, human ---
r_associated #0: 26 -->
en:(aa).col3a1.0
n1=en:complement factor h, human | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=26
- en:cystathionine beta-synthase ---
r_associated #0: 26 -->
en:(aa).col3a1.0
n1=en:cystathionine beta-synthase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=26
- en:dna nucleotidylexotransferase ---
r_associated #0: 26 -->
en:(aa).col3a1.0
n1=en:dna nucleotidylexotransferase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=26
- en:fanconi anemia group c protein ---
r_associated #0: 26 -->
en:(aa).col3a1.0
n1=en:fanconi anemia group c protein | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=26
- en:hemoglobin subunit zeta ---
r_associated #0: 26 -->
en:(aa).col3a1.0
n1=en:hemoglobin subunit zeta | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=26
- en:integrin alpha-l ---
r_associated #0: 26 -->
en:(aa).col3a1.0
n1=en:integrin alpha-l | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=26
- en:beta 2-glycoprotein i ---
r_associated #0: 25 -->
en:(aa).col3a1.0
n1=en:beta 2-glycoprotein i | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=25
- en:beta-globins ---
r_associated #0: 25 -->
en:(aa).col3a1.0
n1=en:beta-globins | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=25
- en:beta-mannosidase ---
r_associated #0: 25 -->
en:(aa).col3a1.0
n1=en:beta-mannosidase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=25
- en:carbonic anhydrase ii ---
r_associated #0: 25 -->
en:(aa).col3a1.0
n1=en:carbonic anhydrase ii | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=25
- en:hemoglobin subunit alpha ---
r_associated #0: 25 -->
en:(aa).col3a1.0
n1=en:hemoglobin subunit alpha | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=25
- en:hydroxymethylbilane synthase ---
r_associated #0: 25 -->
en:(aa).col3a1.0
n1=en:hydroxymethylbilane synthase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=25
- en:phenylalanine hydroxylase ---
r_associated #0: 25 -->
en:(aa).col3a1.0
n1=en:phenylalanine hydroxylase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=25
- en:receptor 4, trail ---
r_associated #0: 25 -->
en:(aa).col3a1.0
n1=en:receptor 4, trail | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=25
- en:stromelysin-3 ---
r_associated #0: 25 -->
en:(aa).col3a1.0
n1=en:stromelysin-3 | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=25
- Thymidylate synthase ---
r_associated #0: 10 -->
en:(aa).col3a1.0
n1=Thymidylate synthase | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=10
- antigène d'activation CD80 des lymphocytes T ---
r_associated #0: 5 -->
en:(aa).col3a1.0
n1=antigène d'activation CD80 des lymphocytes T | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=5
- protéine de la tumeur de Wilms ---
r_associated #0: 5 -->
en:(aa).col3a1.0
n1=protéine de la tumeur de Wilms | n2=en:(aa).col3a1.0 | rel=r_associated | relid=0 | w=5
|